Expression of nitric oxide synthase III in human thyroid follicular cells: Evidence for increased expression in hyperthyroidism

被引:38
作者
Colin, IM
Kopp, P
Zbaren, J
Haberli, A
Grizzle, WE
Jameson, JL
机构
[1] NORTHWESTERN UNIV,CTR ENDOCRINOL METAB & MOL MED,DIV ENDOCRINOL METAB & MOL MED,CHICAGO,IL 60611
[2] UNIV BERN,INSELSPITAL,DEPT MED,RES LABS,CH-3010 BERN,SWITZERLAND
[3] UNIV ALABAMA,DEPT PATHOL,BIRMINGHAM,AL 35294
关键词
D O I
10.1530/eje.0.1360649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nitric oxide mediates a wide array of cellular functions in many tissues. It is generated by three known isoforms of nitric oxide synthases (NOS). Recently the endothelial isoform, NOSIII, was shown to be abundantly expressed in the rat thyroid gland and its expression increased in goitrous glands. In this study, we analyzed whether NOSIII is expressed in human thyroid tissue and whether levels of expression vary in different states of thyroid gland function. Semiquantitative RT-PCR was used to assess variations in NOSIII gene expression in seven patients with Graces' disease, one with a TSH-receptor germline mutation and six hypothyroid patients (Hashimoto's thyroiditis). Protein expression and subcellular localization were determined by immunohistochemistry (two normal thyroids, five multinodular goiters, ten hyperthyroid patients and two hypothyroid patients). NOSIII mRNA was detected in all samples: the levels were significantly higher in tissues from hyperthyroid patients compared with euthyroid and hypothyroid patients. NOSIII immunoreactivity was detected in vascular endothelial cells, but was also found in thyroid follicular cells. In patients with Graves' disease, the immunostaining was diffusely enhanced in all follicular cells. A more intense signal was observed in toxic adenomas and in samples obtained from a patient with severe hyperthyroidism due to an activating mutation in the TSH receptor. In multinodular goiters, large follicles displayed a weak signal whereas small proliferative follicles showed intense immunoreactivity near the apical plasma membrane. In hypothyroid patients, NOSIII immunoreactivity was barely detectable. In summary, NOSIII is expressed both in endothelial. cells and thyroid follicular cells. The endothelial localization of NOSIII is consistent with a role for nitric oxide in the vascular control of the thyroid. NOSIII expression in thyroid follicular cells and the variations in its immunoreactivity suggest a possible role for nitric oxide in thyrocyte function and/or growth.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 32 条
[1]   CULTURE OF HORMONE-DEPENDENT FUNCTIONAL EPITHELIAL-CELLS FROM RAT THYROIDS [J].
AMBESIIMPIOMBATO, FS ;
PARKS, LAM ;
COON, HG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3455-3459
[2]   NITRIC-OXIDE SYNTHASE IN THE RAT ANTERIOR-PITUITARY GLAND AND THE ROLE OF NITRIC-OXIDE IN REGULATION OF LUTEINIZING-HORMONE SECRETION [J].
CECCATELLI, S ;
HULTING, AL ;
ZHANG, X ;
GUSTAFSSON, L ;
VILLAR, M ;
HOKFELT, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :11292-11296
[3]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[4]   DETECTION AND IDENTIFICATION OF ENDOTHELIN-1 IMMUNOREACTIVITY IN RAT AND PORCINE THYROID FOLLICULAR CELLS [J].
COLIN, I ;
BERBINSCHI, A ;
DENEF, JF ;
KETELSLEGERS, JM .
ENDOCRINOLOGY, 1992, 130 (01) :544-546
[5]  
COLIN I, 1995, ENDOTHELINS ENDOCRIN, P157
[6]   EXPRESSION OF THE ENDOTHELIN-1 GENE IN THE RAT-THYROID GLAND AND CHANGES IN ITS PEPTIDE AND MESSENGER-RNA LEVELS IN GOITER FORMATION AND IODIDE-INDUCED INVOLUTION [J].
COLIN, IM ;
SELVAIS, PL ;
REBAI, T ;
MAITER, DM ;
ADAM, E ;
VANDENHOVE, MF ;
KETELSLEGERS, JM ;
DENEF, JF .
JOURNAL OF ENDOCRINOLOGY, 1994, 143 (01) :65-74
[7]   EXPRESSION OF NITRIC-OXIDE SYNTHASE ISOFORMS IN THE THYROID-GLAND - EVIDENCE FOR A ROLE OF NITRIC-OXIDE IN VASCULAR CONTROL DURING GOITER FORMATION [J].
COLIN, IM ;
NAVA, E ;
TOUSSAINT, D ;
MAITER, DM ;
VANDENHOVE, MF ;
LUSCHER, TF ;
KETELSLEGERS, JM ;
DENEF, JF ;
JAMESON, JL .
ENDOCRINOLOGY, 1995, 136 (12) :5283-5290
[8]   ROLE OF NITRIC-OXIDE IN CONTROL OF PROLACTIN-RELEASE BY THE ADENOHYPOPHYSIS [J].
DUVILANSKI, BH ;
ZAMBRUNO, C ;
SEILICOVICH, A ;
PISERA, D ;
LASAGA, M ;
DIAZ, MD ;
BELOVA, N ;
RETTORI, V ;
MCCANN, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (01) :170-174
[9]   NITRIC-OXIDE AS A SIGNAL IN THYROID [J].
ESTEVES, RZ ;
VANSANDE, J ;
DUMONT, JE .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1992, 90 (01) :R1-R3
[10]   Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling [J].
GarciaCardena, G ;
Oh, P ;
Liu, JW ;
Schnitzer, JE ;
Sessa, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) :6448-6453